Almatroodi Saleh A, Rahmani Arshad Husain
Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
Int J Mol Sci. 2025 Apr 28;26(9):4188. doi: 10.3390/ijms26094188.
Myricetin is a natural flavonoid with powerful antioxidant and anti-inflammatory potential commonly found in vegetables, fruits, nuts, and tea. The vital role of this flavonoid in the prevention and treatment of various diseases is evidenced by its ability to reduce inflammation and oxidative stress, maintain tissue architecture, and modulate cell signaling pathways. Thus, this review summarizes recent evidence on myricetin, focusing precisely on its mechanisms of action in various pathogenesis, including obesity, diabetes mellitus, arthritis, osteoporosis, liver, neuro, cardio, and reproductive system-associated pathogenesis. Moreover, it has been revealed that myricetin exhibits anti-microbial properties due to obstructive virulence factors, preventing biofilm formation and disrupting membrane integrity. Additionally, synergistic potential with other drugs and the role of myricetin-based nanoformulations in different diseases are properly discussed. This review seeks to increase the understanding of myricetin's pharmacological potential in various diseases, principally highlighting its effective mechanisms of action. Further wide-ranging research, as well as more randomized and controlled clinical trial studies, should be executed to reconnoiter this compound's therapeutic value, safety, and usefulness against various human pathogenesis.
杨梅素是一种天然黄酮类化合物,具有强大的抗氧化和抗炎潜力,常见于蔬菜、水果、坚果和茶中。这种黄酮类化合物在预防和治疗各种疾病中的重要作用体现在其能够减轻炎症和氧化应激、维持组织结构以及调节细胞信号通路。因此,本综述总结了关于杨梅素的最新证据,重点关注其在各种发病机制中的作用机制,包括肥胖、糖尿病、关节炎、骨质疏松症、肝脏、神经、心脏和生殖系统相关的发病机制。此外,研究表明,杨梅素由于阻碍毒力因子、防止生物膜形成和破坏膜完整性而具有抗菌特性。此外,还适当讨论了杨梅素与其他药物的协同潜力以及基于杨梅素的纳米制剂在不同疾病中的作用。本综述旨在增进对杨梅素在各种疾病中药理潜力的理解,主要突出其有效的作用机制。应该进行更广泛的研究以及更多随机对照临床试验研究,以探究这种化合物对各种人类发病机制的治疗价值、安全性和有效性。
Int J Mol Sci. 2025-4-28
Biomed Pharmacother. 2022-12
Nutrients. 2016-2-16
Drug Deliv Transl Res. 2025-6-30
Toxicol Appl Pharmacol. 2024-7
Molecules. 2024-5-16